Login to Your Account



Pharma: Clinic Roundup


Monday, November 12, 2012
• Chiromics LLC, of Princeton, N.J., is collaborating with London-based GlaxoSmithKline plc to discover new classes of small molecules against certain biological targets. Chiromics' compound collections are assembled using its core chemical technology referred to as cascade catalysis.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription